INTI
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)
$08
About INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
Details
Daily high
$0.08
Daily low
$0.08
Price at open
$0.08
52 Week High
$0.12
52 Week Low
$0.03
Market cap
14.3M
Dividend yield
0.00%
Volume
1,200
Avg. volume
10,077
P/E ratio
-4.35
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. News
Details
Daily high
$0.08
Daily low
$0.08
Price at open
$0.08
52 Week High
$0.12
52 Week Low
$0.03
Market cap
14.3M
Dividend yield
0.00%
Volume
1,200
Avg. volume
10,077
P/E ratio
-4.35